Context: The population of Guadeloupe Island exhibits a high prevalence of obesity.
leptin's effects on controlling energy homeostasis and food intake (4) . Leptin, an adipocyte-derived hormone, modulates insulin secretion and action via the leptin receptor that is expressed in pancreatic b cells, adipose tissue, and muscle (5) . Pathogenic mutations in both LEP and LEPR genes are very rare and have been described in obese individuals worldwide, mainly from consanguineous families (6) . Among the melanocortin receptors and their ligands involved in the central melanocortin system, MC4R was shown to be distributed in several brain regions, including the appetite-regulating nuclei of the hypothalamus (7, 8) . Rare mutations in MC4R were found in 5% to 6% of patients with severe early-onset obesity (9) .
Guadeloupe Island is a French "departement," part of the Lesser Antilles in the Caribbean, with a high prevalence of obesity. To our knowledge, no study has investigated the contribution of gene mutations to childhood obesity in this population with African ancestry.
In the current study, we took advantage of our nextgeneration sequencing panel, which targets all genes involved in monogenic obesity or monogenic diabetes with high sensitivity (10) , to screen 25 Afro-Caribbean children with obesity from Guadeloupe Island.
Materials/Subjects and Methods

Study population
The present investigation included a sample of 25 unrelated children with obesity [standard deviation score (z score) of body mass index (BMI): 2.0 to 2.8] from a previous study on overweight conducted in Guadeloupe Island (11) . This study was performed in 2013 to evaluate the basal data of middle school children between 11 and 15 years of age and to evaluate the changes in the children's profiles after 1 year of a lifestyle intervention program.
The study was approved by the ethic committee (South West, Overseas III, Bordeaux, France) in October 2012 and the French National Agency for Medicines and Health Products Safety. Written informed consent for participation in this study was obtained from all children and their parents. The children and accompanying parents were interviewed.
Anthropometric measurements were obtained by trained nurses. Height in centimeters (cm) and weight in kilograms (kg) were measured with participants standing without shoes and lightly clothed. BMI was calculated as weight/height 2 (kg/m 2 ). The BMI z score was calculated as [(measured value 2 average value in the reference population)/standard deviation in the reference population] using a pediatric z score calculator. Pubertal stage was assessed according to Tanner (12) . Tanner stages 3, 4, and 5 defined pubertal/postpubertal development. Family history of obesity or diabetes was available only for the accompanying parent (mother or father).
Laboratory measurements
Blood samples were collected by venipuncture for adipokine and hormone estimations and for DNA extractions after an overnight fast. Blood lipid and blood glucose (mmol/L), serum insulin (mU/mL), leptin (ng/mL), and total adiponectin (mg/mL) levels were measured as previously described (11) . Blood lipid abnormalities were defined as high-density lipoprotein cholesterol ,1.03 mmol/L or triglycerides $1.7 mmol/L (13). The homeostasis model assessment to determine insulin resistance (HOMA-IR) was calculated using the following formula: [fasting insulin (mIU/mL) 3 fasting glucose (mmol/L)/22.5] (14). Insulin resistance was defined by a HOMA-IR .3.16 (15) .
Genomic DNA was extracted from whole blood using the Gentra Puregene Blood Kit (Qiagen, Crawley, UK) per manufacturer's instructions.
Next-generation sequencing
The coding regions (including at least 40 base pairs of the flanking intron of each exon) of 59 genes involved in monogenic forms of obesity or diabetes (Table 1) were sequenced in the 25 children. For this purpose, we used targeted polymerase chain reaction-based enrichment in lipid microdroplets (RainDance Technologies, Lexington, MA) in combination with Illumina sequencing (San Diego, CA) as previously described by us (10, 16) . The reads were mapped to the hg19 human genome assembly, and genetic variants (punctual mutations and insertions/deletions) were detected as previously described (10) . The mean depth of coverage was between 2403 and 4283 [median (first quartile -third quartile): 318 (286-352)], and 99% of the target on average was covered with more than eight reads. The rare variants of potential interest described later had a high quality (Phred) score of at least 50 (mean quality score of 170). We used standards and guidelines of the American College of Medical Genetics and Genomics for the interpretation of sequence variants (17) . Of note, we were unfortunately not able to sequence DNA samples from the relatives of the children carrying loss-of-function mutations.
Statistical analysis
A descriptive analysis of children carrying gene mutations was performed.
Data are presented as mean 6 standard deviation for quantitative parameters and as percentage for categorical parameters.
Results
The 25 obese children from Guadeloupe Island were 12 boys and 13 girls. The mean age of the study population was 12.4 6 1.1 years (12.3 6 1.2 years in boys and 12.2 6 1.1 years in girls). All the children were at a pubertal or postpubertal stage (Tanner stage $3). Tanner stage was distributed as follows: in boys, five at stage 3, five at stage 4, and two at stage 5; in girls, nine at stage 3 and four at stage 4. BMI z scores ranged from 2.00 to 2.80. Seventeen children (68%) had insulin-resistance (HOMA-IR .3.16). A family history of obesity (mother or father) was observed in eight children, and three of the accompanying parents presented with type 2 diabetes. All the children had abnormal eating behavior, favoring foods that were too sweet, rich in fat, and high in calories and (Tables 2 and 3 ). This mutation was not present in the gnomAD browser and was predicted to be damaging according to every in silico prediction tool used in the current study (i.e., SIFT, MutationTaster, Align GVGD, and PolyPhen-2). Of note, we also found that the boy (ID #1) carried a rare nonsynonymous mutation (p.Thr1068Met) in ABCC8. This mutation was not novel (rs139524121; with a frequency of 0.32% in Africans according to the gnomAD browser) and was damaging according to one in silico prediction tool. Of note, the mother of this boy was obese and had type 2 diabetes, but we were unable to sequence her DNA.
• A severely obese girl (ID #2; BMI, 36.6 kg/m 2 ; BMI z score, 2.43; age, 13.5 years) who presented with severe insulin resistance and impaired fasting plasma glucose level (.5.6 mmol/L) according to the 2017 American Diabetes Association guidelines (19) and carried a nonsynonymous mutation (p.Leu140Phe) in NTRK2 (Tables 2 and 3 ). This mutation was not novel (rs150692457; with a frequency of 0.43% in Africans according to the gnomAD browser), and it was damaging according to two in silico prediction tools.
• An obese boy (ID #3; BMI, 30.4 kg/m 2 ; BMI z score, 2.22; age, 12.7 years) who presented with insulin resistance and carried a nonsynonymous mutation (p.Pro90His) in SH2B1 (Tables 2 and 3 ). This mutation was not novel (rs149091795; with a frequency of 0.47% in Africans according to the gnomAD browser) and was not damaging according to the four in silico prediction tools.
• An obese girl (ID #4; BMI, 29.7 kg/m 2 ; BMI z score, 2.14; age, 11.9 years) who presented with insulin resistance and carried a nonsynonymous mutation (p.Ser343Pro) in SIM1 (Tables 2 and 3 ). This mutation was not present in the gnomAD browser and was damaging according to three in silico prediction tools.
• A morbidly obese girl (ID #5; BMI, 51.2 kg/m 2 ; BMI z score, 2.80; age, 14.7 years) who presented with insulin resistance and carried a frameshift mutation (p.Val326Thrfs*43) in SIM1 (Tables 2 and 3 ). This mutation was not present in the gnomAD browser and was probably deleterious because it led to a premature STOP codon in the reading frame. Of note, the girl (ID #5) also presented with an impaired fasting glucose level (Table 2 ) and carried a rare nonsynonymous mutation (p.Ala625Val) in ABCC8. This mutation was not novel (rs148709148; with a frequency of 0.21% in Africans according to the gnomAD browser), and it was damaging according to one in silico prediction tool.
In parallel, we found five obese girls and boys (ID #6 through ID #10) carrying a rare heterozygous missense Abbreviations: F, female; HDL-C, high-density lipoprotein cholesterol; IR, insulin resistance; M, male; TG, triglycerides.
a The values previously reported in nonobese adolescents were (mean 6 standard deviation): fasting glucose, 4.9 6 0.1 mmol/L; fasting insulin, 11 6 1.4 mIU/mL; leptin, 5 6 1 ng/mL; and adiponectin, 14.0 6 1.6 mg/mL (18). Tables 2 and 3 ). The p.Lys1521Asn mutation in ABCC8 was identified in two obese girls (ID #6 and ID #7), including one with an impaired fasting plasma glucose level (Table 2 ). This mutation was not novel (rs142272833; with a frequency of 0.43% in Africans according to the gnomAD browser), and it was damaging according to one in silico prediction tool. Of note, the mothers of these two girls had type 2 diabetes, but we were unable to sequence their DNA. The ABCC8 p.Ala625Val mutation (carried by ID #8) was described previously because it was also carried by the girl with ID #5. Finally, we found two mutations (p.Val13Met, p.Val151Met) in KCNJ11 in two obese boys (ID #9 and ID #10) with normal glucose levels (Tables 2 and 3 ). These two mutations were very rare (,0.1% in Africans according to the gnomAD browser), and they were both damaging according to several in silico prediction tools.
Discussion
In the multiethnic population of Guadeloupe Island that includes 472,124 inhabitants, 80% of subjects are of African descent (known as African-Caribbeans). On this island, overweight and obesity were recently estimated at 23% and 9%, respectively, among children aged 5 to 14 years. Diabetes is also highly prevalent (.8%) in the adult population. In the current study, which included 25 obese children of African-Caribbean ancestry, we found five mutations of potential interest in four genes involved in monogenic obesity. The MC4R p.Ile301Thr mutation that we identified in an obese boy (ID #1) was previously reported in a morbidly obese adult (20) . We showed that this mutation leads to a reduction in MC4R activation (20) . Furthermore, the specific binding of the [ 125 I]NDP-aMSH MC4R agonist to the p.Ile301Thr mutant was reduced by more than 80% compared with the wild-type receptor (20) . Therefore, the MC4R p.Ile301Thr mutation was pathogenic and probably caused obesity in the boy. However, the ABCC8 p.Thr1068Met mutation carried by the same boy was of uncertain significance.
The NTRK2 p.Leu140Phe mutation carried by the severely obese girl (ID #2) was previously associated with smoking status in Africans (21) . However, according to our knowledge, no NTRK2 mutation causing monogenic obesity has been identified since the primary study by Yeo et al. (22) . The girl did not have an intellectual disability, in contrast to the previously reported subject with a mutation for NTRK2 (22) . With regard to the frequency of the present mutation and its effect prediction, the NTRK2 p.Leu140Phe mutation was of uncertain significance. Further conclusive studies are needed on this case.
The SH2B1 p.Pro90His mutation carried by an obese boy (ID #3) did not appear to be pathogenic with regard to its frequency and prediction effect. However, Doche et al. (23) considered it pathogenic as they demonstrated that this rare nonsynonymous mutation significantly impaired the ability of SH2B1b to enhance neuronal differentiation compared with the wild-type protein.
Furthermore, in contrast to the wild-type protein, which was stimulated with both basal and growth hormoneinduced motilities, the p.Pro90His mutation inhibited growth hormone-induced motility (23) . In line with the phenotype of the boy analyzed in the current study, the two carriers reported in Doche et al. (23) presented with hyperinsulinemia. Of note, they also presented with social isolation and aggression, which is not the case with the boy from the current study. The SH2B1 p.Pro90His mutation possibly caused obesity in the boy, although further investigation is needed to confirm this result. Neither the SIM1 p.Ser343Pro nor the p.Val326Thrfs*43 mutation carried by two obese girls (ID #4 and ID #5) has been previously described, according to our knowledge. We and others previously demonstrated that rare lossof-function mutations in SIM1 caused obesity potentially associated with Prader-Willi-like clinical features (24) (25) (26) . In the current study, we did not notice any intellectual disability, compulsive eating, neonatal hypotonia, or other features related to Prader-Willi-like syndrome. However, the two rare mutations in SIM1 probably caused obesity in the two girls. The ABCC8 p.Ala625Val mutation carried by the morbidly obese girl (ID #5) was of uncertain significance.
In parallel, we found rare heterozygous missense mutations in ABCC8 and KCNJ11 in five obese girls and boys (ID #6 through ID #10). The ABCC8 p.Lys1521Asn mutation was previously associated with adult-onset type 2 diabetes, but investigations failed to show a functional effect of this mutation on protein activity (27) . Therefore, this mutation was of uncertain significance. The other ABCC8 mutation (p.Ala625Val) was of uncertain significance, as well as the two mutations (p.Val13Met, p.Val151Met) in KCNJ11 carried by two obese boys (ID #9 and ID #10).
In summary, among 25 obese children, we identified three carriers of pathogenic or likely pathogenic mutations in SIM1, MC4R, and SH2B1, which probably caused the obesity. Therefore, we were able to detect mutations linked to severe obesity in more than 15% of this population, which is higher than what we found in Europeans (;5%) (3).
Limitations of our study include its small sample size; however, its strength is related to the fact that it concerns a homogeneous sample of Afro-Caribbean children with obesity. Larger family and longitudinal studies in this population appear relevant for the screening of monogenic obesity/diabetes genes.
